Clinical Trials
758 trialsRECT
University Hospital, Bordeaux
GRECCAR12
University Hospital, Bordeaux
Paula Method of Exercises in Patients With LARS Syndrome:Randomized Controlled Trial
Hadassah Medical Organization
Bowel Dysfunction After Low Rectal Resection. An Pilot Study Using Psyllium Husk In Rectal Cancer Patients.
Sykehuset Telemark
NOAHS-ARC
Servicio de Salud Metropolitano Sur Oriente
The Safety and Efficiency of Stent-based Diverting Technique Versus Ileostomy in Rectal Cancer Patients
Sir Run Run Shaw Hospital
COMPANION-003
Compass Therapeutics
EMOTION
Centre Antoine Lacassagne
ETAP
Institut Paoli-Calmettes
NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Canadian Cancer Trials Group
A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
METCAP
Centre Oscar Lambret
QUALIPRO
Centre Oscar Lambret
Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea
Tianjin Medical University Cancer Institute and Hospital
00-046
Memorial Sloan Kettering Cancer Center
A Clinical Study Based on FAPI-PET/CT Technology to Predict Pathological Complete Response After Neoadjuvant Chemoradiotherapy for MSS Rectal Cancer
Sun Yat-sen University
Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer
Institute of Oncology Ljubljana
Intraoperative Assessment of Distal Resection Margins Using Frozen Section in Mid and Low Rectal Cancer Surgery
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
SWOG Cancer Research Network
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Roswell Park Cancer Institute
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
Dex
The Second Affiliated Hospital of Chongqing Medical University
ICCAUT-1
The First Hospital of Jilin University
TAP
Trinity Health Michigan
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
City of Hope Medical Center
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
University of California, San Francisco
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
PeLear CCC
University of North Carolina, Chapel Hill
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer
Changhai Hospital
GRECCAR8
Hospices Civils de Lyon
SUCCEED
University of California, San Francisco
SHORT
Providence Health & Services
Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
National Cancer Institute (NCI)
AMIREMBOL
Centre Hospitalier Universitaire de Nīmes
AYAConnect
UNC Lineberger Comprehensive Cancer Center
NEAPE
Umeå University
METEORR
Institut Bergonié
MTM-COLON-II
Centre Hospitalier Universitaire, Amiens
RIFIONA
Centre Hospitalier Universitaire, Amiens
Single-port Robotic Transanal Total Mesorectal Excision
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Compare Preperitoneal Analgesia to Epidural Analgesia for Pain Control After Colon and Rectal Surgery
Trinity Health Michigan
FIDURA
Sahlgrenska University Hospital
AMPLIFY-201
Elicio Therapeutics
CASCADOR
Institut Bergonié
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
City of Hope Medical Center
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Academic and Community Cancer Research United
Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins